Reconvalescent blood products, Passive vaccine
| Zeile 26: | Zeile 26: | ||
{{tp|p=32217555|t=2020. Covid-19: FDA approves use of convalescent plasma to treat critically ill patients |pdf=|usr=}} | {{tp|p=32217555|t=2020. Covid-19: FDA approves use of convalescent plasma to treat critically ill patients |pdf=|usr=}} | ||
{{ttp|p=32369628|t=2020. Convalescent donor SARS-COV-2-specific cytotoxic T lymphocyte infusion as a possible treatment option for COVID-19 patients with severe disease has not received enough attention till date |pdf=|usr=}} | {{ttp|p=32369628|t=2020. Convalescent donor SARS-COV-2-specific cytotoxic T lymphocyte infusion as a possible treatment option for COVID-19 patients with severe disease has not received enough attention till date |pdf=|usr=}} | ||
| + | {{tp|p=32310190|t=2020. Coronavirus drugs: Using plasma from recovered patients as a treatment for COVID-19 |pdf=|usr=}} | ||
| + | {{tp|p=32356910|t=2020. Convalescent plasma transfusion for the treatment of COVID-19: Systematic review |pdf=|usr=}} | ||
| + | {{tp|p=32293713|t=2020. Treatment with convalescent plasma for COVID-19 patients in Wuhan, China |pdf=|usr=}} | ||
| + | {{tp|p=32281679|t=2020. COVID-19: Herd Immunity and Convalescent Plasma Transfer Therapy |pdf=|usr=}} | ||
| + | {{tp|p=32380316|t=2020. Convalescent plasma in Covid-19: Possible mechanisms of action |pdf=|usr=}} | ||
| + | {{tp|p=32324899|t=2020. Operational protocol for donation of anti-COVID-19 convalescent plasma in Italy |pdf=|usr=}} | ||
| + | {{tp|p=32319102|t=2020. Points to consider in the preparation and transfusion of COVID-19 convalescent plasma |pdf=|usr=}} | ||
| + | {{tp|p=32240545|t=2020. Collecting and evaluating convalescent plasma for COVID-19 treatment: why and how?|pdf=|usr=}} | ||
| + | {{tp|p=32374891|t=2020. Convalescent plasma to treat coronavirus disease 2019 (COVID-19): considerations for clinical trial design |pdf=|usr=}} | ||
| + | {{tp|p=32374890|t=2020. COVID-19 convalescent plasma: phase 2 |pdf=|usr=}} | ||
| + | {{tp|p=32219429|t=2020. Convalescent Plasma to Treat COVID-19: Possibilities and Challenges |pdf=|usr=}} | ||
| + | {{tp|p=32352484|t=2020. Testing an Old Therapy Against a New Disease: Convalescent Plasma for COVID-19 |pdf=|usr=}} | ||
| + | {{ttp|p=32344202|t=2020. Impact of immune enhancement on Covid-19 polyclonal hyperimmune globulin therapy and vaccine development |pdf=|usr=}} | ||
| + | {{tp|p=32281318|t=2020. Convalescent Plasma Therapy for Corona Virus Disease 2019: a Long Way to Go but Worth Trying |pdf=|usr=}} | ||
| + | {{tp|p=32359447|t=2020. The resurgence of convalescent plasma therapy |pdf=|usr=}} | ||
| + | {{ttp|p=32197324|t=2020. A Review on Applications of Computational Methods in Drug Screening and Design |pdf=|usr=}} | ||
| + | |||
| + | {{tp|p=32448638|t=2020. Convalescent plasma, an apheresis research project targeting and motivating the fully recovered COVID 19 patients: A rousing message of clinical benefit to both donors and recipients alike |pdf=|usr=}} | ||
| + | {{tp|p=32417123|t=ä. Convalescent plasma, an apheresis research project targeting and motivating the fully recovered COVID 19 patients: A rousing message of clinical benefit to both donors and recipients alike |pdf=|usr=}} | ||
Version vom 21. Juni 2020, 12:42 Uhr
32243945 ä. Treatment With Convalescent Plasma for Critically Ill Patients With SARS-CoV-2 Infection
32375025 ä. Structural Basis for Potent Neutralization of Betacoronaviruses by Single-Domain Camelid Antibodies
32344202 2020. Impact of immune enhancement on Covid-19 polyclonal hyperimmune globulin therapy and vaccine development
32298745 ä. Successful treatment of plasma exchange followed by intravenous immunogloblin in a critically ill patient with 2019 novel coronavirus infection
32226289 2020. Perspectives on therapeutic neutralizing antibodies against the Novel Coronavirus SARS-CoV-2
32218340 2020. Could Intravenous Immunoglobulin Collected from Recovered Coronavirus Patients Protect against COVID-19 and Strengthen the Immune System of New Patients?
32254064 2020. Deployment of convalescent plasma for the prevention and treatment of COVID-19
32305026 ä. Challenges of Convalescent Plasma Therapy on COVID-19
32167489 ä. The convalescent sera option for containing COVID-19
32348485 ä. Effect of Convalescent Plasma Therapy on Viral Shedding and Survival in COVID-19 Patients
| 32249185 ä. Duration of serum neutralizing antibodies for SARS-CoV-2: Lessons from SARS-CoV infection |
32281317 2020. Use of Convalescent Plasma Therapy in Two COVID-19 Patients with Acute Respiratory Distress Syndrome in Korea
32219428 2020. Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma
32313872 ä. COVID-19 convalescent plasma transfusion
32113510 2020. Convalescent plasma as a potential therapy for COVID-19
C7158785 ä. Convalescent plasma: A possible treatment of COVID-19 in India
32343358 2020. Immunoglobulins or convalescent plasma to tackle COVID-19: buying time to save lives - current situation and perspectives
32253318 2020. Effectiveness of convalescent plasma therapy in severe COVID-19 patients
32345485 ä. Treatment for emerging viruses: Convalescent plasma and COVID-19
32380316 ä. Convalescent plasma in Covid-19: Possible mechanisms of action
32359789 ä. COVID-19 Convalescent Plasma: Now Is the Time for Better Science
32359788 ä. Convalescent Plasma: Therapeutic Hope or Hopeless Strategy in the SARS-CoV-2 Pandemic
32217555 2020. Covid-19: FDA approves use of convalescent plasma to treat critically ill patients
| 32369628 2020. Convalescent donor SARS-COV-2-specific cytotoxic T lymphocyte infusion as a possible treatment option for COVID-19 patients with severe disease has not received enough attention till date |
32310190 2020. Coronavirus drugs: Using plasma from recovered patients as a treatment for COVID-19
32356910 2020. Convalescent plasma transfusion for the treatment of COVID-19: Systematic review
32293713 2020. Treatment with convalescent plasma for COVID-19 patients in Wuhan, China
32281679 2020. COVID-19: Herd Immunity and Convalescent Plasma Transfer Therapy
32380316 2020. Convalescent plasma in Covid-19: Possible mechanisms of action
32324899 2020. Operational protocol for donation of anti-COVID-19 convalescent plasma in Italy
32319102 2020. Points to consider in the preparation and transfusion of COVID-19 convalescent plasma
32240545 2020. Collecting and evaluating convalescent plasma for COVID-19 treatment: why and how?
32374891 2020. Convalescent plasma to treat coronavirus disease 2019 (COVID-19): considerations for clinical trial design
32374890 2020. COVID-19 convalescent plasma: phase 2
32219429 2020. Convalescent Plasma to Treat COVID-19: Possibilities and Challenges
32352484 2020. Testing an Old Therapy Against a New Disease: Convalescent Plasma for COVID-19
| 32344202 2020. Impact of immune enhancement on Covid-19 polyclonal hyperimmune globulin therapy and vaccine development |
32281318 2020. Convalescent Plasma Therapy for Corona Virus Disease 2019: a Long Way to Go but Worth Trying
32359447 2020. The resurgence of convalescent plasma therapy
| 32197324 2020. A Review on Applications of Computational Methods in Drug Screening and Design |
32448638 2020. Convalescent plasma, an apheresis research project targeting and motivating the fully recovered COVID 19 patients: A rousing message of clinical benefit to both donors and recipients alike
32417123 ä. Convalescent plasma, an apheresis research project targeting and motivating the fully recovered COVID 19 patients: A rousing message of clinical benefit to both donors and recipients alike
